CHGCY (Chugai Pharmaceutical Co) Margin of Safety % (DCF FCF Based): 8.62% (As of Jun. 24, 2026)


CHGCY Chugai Pharmaceutical Co Ltd CHGCY
92 GF Score
Price $22.99
GF Value $24.28
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co Margin of Safety % (DCF FCF Based)?

Chugai Pharmaceutical Co CHGCY +0.13% 92 Margin of Safety % (DCF FCF Based) is 8.62% as of Jun. 24, 2026. GuruFocus rates CHGCY with a GF Score™ of 92/100 and a GF Value™ of $24.28 (Fairly Valued). The stock has 1 warning sign investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-24), Chugai Pharmaceutical Co's Predictability Rank is 4-Stars. Chugai Pharmaceutical Co's intrinsic value calculated from the Discounted FCF model is $34.55 and current share price is $22.99. Consequently,

Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) using Discounted FCF model is 8.62%.

CHGCY vs LLY, JNJ, ABBV: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) falls into.


CHGCY
92GF Score
Chugai Pharmaceutical Co Ltd CHGCY
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co Margin of Safety % (DCF FCF Based) Calculation

Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(25.16-22.99)/25.16
=8.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of 8.62% mean?
Chugai Pharmaceutical Co (CHGCY) has a Margin of Safety % (DCF FCF Based) of 8.62% as of Jun. 24, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Chugai Pharmaceutical Co.
Is Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) too high?
Chugai Pharmaceutical Co's current Margin of Safety % (DCF FCF Based) is 8.62%. Overall, Chugai Pharmaceutical Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) compare to LLY and JNJ?
Chugai Pharmaceutical Co's Margin of Safety % (DCF FCF Based) of 8.62% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF FCF Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Chugai Pharmaceutical Co. Chugai Pharmaceutical Co's current Margin of Safety % (DCF FCF Based) is 8.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (CHGCY) is currently considered Fairly Valued. The stock's GF Value™ is $24.28, compared to a current price of $22.99 — trading 5.3% below its estimated fair value. The current Margin of Safety % (DCF FCF Based) is 8.62%. Chugai Pharmaceutical Co's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For Chugai Pharmaceutical Co (CHGCY), the current Margin of Safety % (DCF FCF Based) is 8.62% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (CHGCY) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of $22.99 is trading 5.3% below its estimated GF Value™ of $24.28. GuruFocus considers Chugai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for CHGCY:

  • Margin of Safety % (DCF FCF Based): 8.62%
  • GF Value™: $24.28 vs. price of $22.99 (5.3% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the CHGCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
92GF Score

Get the complete analysis for CHGCY

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.99
Price
$24.28
GF Value